adenosine monophosphate has been researched along with Emergencies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boucher, HW; Ison, MG; Wolfe, C | 1 |
| Aknouche, S; Allard, J; Blanc, R; Ciccio, G; Delvoye, F; Desilles, JP; Escalard, S; Hebert, S; Labreuche, J; Maertens de Noordhout, A; Maier, B; Mazighi, M; Obadia, M; Olivot, JM; Piotin, M; Redjem, H; Sabben, C; Smajda, S; Thion, LA | 1 |
2 other study(ies) available for adenosine monophosphate and Emergencies
| Article | Year |
|---|---|
Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Approval; Emergencies; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; United States | 2020 |
Antiplatelet Therapy During Emergent Extracranial Internal Carotid Artery Stenting: Comparison of Three Intravenous Antiplatelet Perioperative Strategies.
Topics: Abciximab; Adenosine Monophosphate; Administration, Intravenous; Aged; Aspirin; Carotid Artery, Internal; Carotid Stenosis; Drug Administration Schedule; Emergencies; Endovascular Procedures; Female; Humans; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Stents; Time Factors; Treatment Outcome | 2021 |